Carlsmed, Inc. CARL
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 17.52% | 6.27% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 17.52% | 6.27% | |||
| Cost of Revenue | 19.15% | 3.77% | |||
| Gross Profit | 17.04% | 7.04% | |||
| SG&A Expenses | 18.25% | 5.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 18.05% | 3.71% | |||
| Operating Income | -18.97% | 0.45% | |||
| Income Before Tax | -20.86% | -0.96% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -20.86% | -0.96% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -20.86% | -0.96% | |||
| EBIT | -18.97% | 0.45% | |||
| EBITDA | -18.84% | 0.47% | |||
| EPS Basic | -19.29% | -0.06% | |||
| Normalized Basic EPS | -19.31% | -0.05% | |||
| EPS Diluted | -19.29% | -0.06% | |||
| Normalized Diluted EPS | -19.31% | -0.05% | |||
| Average Basic Shares Outstanding | 1.32% | 0.90% | |||
| Average Diluted Shares Outstanding | 1.32% | 0.90% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||